Jéssica Almeida Batista-Gomes

Jéssica Almeida Batista-Gomes

Auto-generated profile, based on publicly available information

Jéssica Almeida Batista-Gomes

Affiliation Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
André Salim KhayatAndré Salim Khayat
André Salim Khayat
PAPaulo Pimentel de Assumpção
Paulo Pimentel de Assumpção
BKBruna Claudia Meireles Khayat
Bruna Claudia Meireles Khayat
TATaíssa Maíra Thomaz Araújo
Taíssa Maíra Thomaz Araújo
JBJéssica Almeida Batista-Gomes
Jéssica Almeida Batista-Gomes
SSSidney Emmanuel Batista dos Santos
Sidney Emmanuel Batista dos Santos
The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, there are ACE2 polymorphisms that could influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.

29 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
André Salim KhayatAndré Salim Khayat
André Salim Khayat
PAPaulo Assumpcao
Paulo Assumpcao
BKBruna Claudia Meireles Khayat
Bruna Claudia Meireles Khayat
TATaíssa Maíra Thomaz Araújo
Taíssa Maíra Thomaz Araújo
JBJéssica Almeida Batista-Gomes
Jéssica Almeida Batista-Gomes
SSSidney Santos
Sidney Santos
The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, ACE2 polymorphisms should influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.

26 June 2020 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
JBJéssica Almeida Batista-Gomes
Jéssica Almeida Batista-Gomes
FMFernando Augusto Rodrigues Mello
Fernando Augusto Rodrigues Mello
Edivaldo HERCULANO CORREA de OliveiraEdivaldo HERCULANO CORREA de Oliveira
Edivaldo HERCULANO CORREA de Oliveira
MSMichel Platini Caldas de Souza
Michel Platini Caldas de Souza
AWAlayde Vieira Wanderley
Alayde Vieira Wanderley
André Salim KhayatAndré Salim Khayat
André Salim Khayat
Copy number variations (CNVs) analysis may reveal molecular biomarkers and provide information on the pathogenesis of acute lymphoblastic leukemia (ALL). We investigated the gene copy number in childhood ALL by microarray and select three new recurrent CNVs to evaluate by real-time PCR assay: DMBT1, KIAA0125 and PRDM16 were selected due to high frequency of CNVs in ALL samples and based on their potential biological functions in carcinogenesis described in the literature. DBMT1 deletion was associated with patients with chromosomal translocations and is a potential tumor suppressor; KIAA0125 and PRDM16 may act as an oncogene despite having a paradoxical behavior in carcinogenesis. This study reinforces that microarrays/aCGH is it is a powerful tool for detection of genomic aberrations, which may be used in the risk stratification.